NCT01684566 - A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Oral Mucositis

Interventions

DEVICE

episil(R)

episil® is a lipid-based liquid that spreads onto mucosal surfaces and transforms into a protective, strongly bioadhesive FluidCrystal® film after intraoral administration.

OTHER

Oral hygiene procedures

Oral hygiene by using toothbrush, toothpaste, lip balm and dental floss (if available)

Trial Locations (12)

22185

Lund University Hospital, Lund

31096

Rambam Health Care Campus, Haifa

37099

Abteilung fur Hamatologie und Onkologie Universitatsmedizin an der Georg-August-Universitat, Göttingen

49100

Rabin Medical Center, Petah Tikva

64239

The Tel-Aviv Sourasky Medical Centre, Tel Aviv

75185

Uppsala University Hospital, Uppsala

91240

Hadassah Medical Centre, Jerusalem

01307

Med Klinik und Poliklinik I Universitatsklinikum Carl Gustav Carus, Dresden

01141

Military Institute of Medicine Internal diseases and Haemtalogy Clinic, Warsaw

02776

Institute of Haematology and Transfusion Medicine, Warsaw

02781

Oncology Center Institute named Maria Sklodowska-Curie Lymph System Cancer Clinic, Warsaw

141 04

Karin Garming-Legert, Stockholm